Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (831-840 of 1,052) with videos related to

Pageof 106
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Solid cancers after bone marrow transplantationS Bhatia, A D Louie, R Bhatia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood|March 1, 1997
Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancerG Somlo, I Sniecinski, T Odom-Maryon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study ReportAndrew M McDonald, Yanjun Chen, Jessica Wu, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
American Journal of Hematology|September 18, 2020
Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidencePayal Shah, Silvie Suriany, Roberta Kato, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Journal of Cellular Physiology|January 10, 2019
The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AMLLe Xuan Truong Nguyen, Estelle Troadec, Arjun Kalvala, et al.
Blood|February 11, 2005
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor StudySmita Bhatia, Leslie L Robison, Liton Francisco, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
Pageof 106

Showing results (831-840 of 1,052) with videos related to

Sort By:
Pageof 106
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Solid cancers after bone marrow transplantationS Bhatia, A D Louie, R Bhatia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood|March 1, 1997
Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancerG Somlo, I Sniecinski, T Odom-Maryon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study ReportAndrew M McDonald, Yanjun Chen, Jessica Wu, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
American Journal of Hematology|September 18, 2020
Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidencePayal Shah, Silvie Suriany, Roberta Kato, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Journal of Cellular Physiology|January 10, 2019
The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AMLLe Xuan Truong Nguyen, Estelle Troadec, Arjun Kalvala, et al.
Blood|February 11, 2005
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor StudySmita Bhatia, Leslie L Robison, Liton Francisco, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
Pageof 106